- Book
- April 2022
North America
- Book
- November 2021
North America
- Book
- September 2021
North America
- Book
- July 2021
North America
- Book
- June 2021
North America
- Book
- April 2021
North America
- Book
- January 2021
North America
- Book
- November 2020
North America
- Book
- October 2020
North America
- Book
- September 2020
North America
- Book
- July 2020
North America
- Book
- March 2020
North America
- Book
- November 2019
North America
- Book
- November 2019
North America
- Book
- July 2019
North America
- Book
- May 2019
North America

Otorhinolaryngology is a branch of medicine that focuses on the diagnosis and treatment of diseases and disorders of the ear, nose, and throat. It is an important field in drug discovery, as many of the drugs used to treat these conditions are developed through research and clinical trials. Otorhinolaryngology is a rapidly evolving field, with new treatments and therapies being developed to address a wide range of conditions.
Drug discovery in otorhinolaryngology is a complex process that involves the identification of new compounds, the development of new drugs, and the testing of these drugs in clinical trials. The process is often lengthy and expensive, but the potential rewards are great. New drugs can provide relief to patients suffering from a variety of conditions, and can also lead to improved quality of life.
Some of the major companies in the otorhinolaryngology market include GlaxoSmithKline, Merck, Pfizer, Novartis, and Sanofi. These companies are involved in the development of new drugs and treatments for a variety of conditions, including allergies, hearing loss, and sinusitis. They are also involved in the research and development of new technologies and treatments for otorhinolaryngology. Show Less Read more